Overactive bladder drugs on Wellcare Value Script (S4802-161)
Oxybutynin, solifenacin, Myrbetriq and Gemtesa, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Nevada
- Premium
- $2.70/month
- Deductible
- $615.00, doesn't apply to tier 1 and 2
6 of 7 Overactive bladder drugs are covered on this plan. None require prior authorization.
1 isn't on the formulary (Myrbetriq).
- from $11.70Tier 4
- from $14.94Tier 4
- from $44.70Tier 3
- $192.57Tier 4
- from $20.42Tier 4
- from $13.30Tier 3
Not on the formulary
Myrbetriq
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.